Chargement en cours...
Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer’s Disease
BACKGROUND: The ideal participants for Alzheimer’s disease (AD) clinical trials would show cognitive decline in the absence of treatment (i.e., placebo arm) and also would be responsive to the therapeutic intervention being studied (i.e., drug arm). One strategy to boost the power of trials is to en...
Enregistré dans:
| Publié dans: | J Alzheimers Dis |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201366/ https://ncbi.nlm.nih.gov/pubmed/31985462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-190822 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|